Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
NIH NCI

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 31 March 2000:
Vol. 287. no. 5462, pp. 2396 - 2398
DOI: 10.1126/science.287.5462.2396
Prev | Table of Contents | Next

News Focus

SCIENCE INTERVIEW:
In the Crossfire: Collins on Genomes, Patents, and 'Rivalry'

The public effort to sequence the human genome is facing a huge challenge on several levels from a privately funded team at Celera Genomics in Rockville, Maryland. Both teams are racing to complete a draft of the human genome in the next few months, and both are engaged in a vigorous, and sometimes noisy, competition. In a meeting on 14 March, Science asked Francis Collins, head of the National Human Genome Research Institute, to discuss his views on this controversy, the rivalry with Celera, and future priorities of the Human Genome Project.

Read the Full Text

ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)